GlassScriptPhysician profile
Paul M Ryan
NPI 1770555393
$14,078.90
in general payments reported to CMS, 2019-2025
28 companies · $3,050 in 2025
The $3,050 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.12 · 2022: $9,282 · 2023: $1,326 · 2024: $361 · 2025: $3,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Consulting Fee: $2,000 · Travel and Lodging: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.71 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $600.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,359.83 | 2022 | |
| Bone Support INC. | $2,000.00 | 2025 | Ceramentbone Void Filler, Cerament G |
| Evolution Surgical, INC | $1,659.14 | 2022-2024 | |
| Sequoia Surgical, INC. | $1,200.00 | 2022 | |
| Cornerstone Medical Associates, INC. | $1,023.00 | 2022 | |
| Medical Device Business Services, INC. | $649.25 | 2023 | |
| Depuy Synthes Sales INC. | $596.23 | 2023-2025 | Unium, Na, Monovisc |
| Goode Surgical INC | $232.53 | 2025 | |
| Exactech, INC. | $197.92 | 2019-2023 | |
| Vertex Pharmaceuticals Incorporated | $181.96 | 2024-2025 | |
| Paragon 28, INC. | $174.01 | 2022-2025 | Additive Orthopedics |
| Musculoskeletal Transplant Foundation INC. | $166.73 | 2023 | |
| Smith+Nephew, INC. | $143.54 | 2022-2025 | Grafix Pl, Renasys Touch, Grafix |
| Vericel Corporation | $72.33 | 2024 | Maci |
| Bioventus LLC | $48.25 | 2023-2025 | Exogen Ultrasound Bone Healing System, Durolane |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $47.40 | 2024 | Puraply Am |
| Linvatec Corporation | $46.33 | 2025 | Biobrace 23mm |
| Pacira Pharmaceuticals Incorporated | $43.30 | 2024-2025 | Exparel, Iovera, Zilretta |
| Medshape, INC. | $39.57 | 2025 | Dynanail |
| Biotissue Holdings INC. | $39.00 | 2022 | |
| Solventum Corporation | $33.35 | 2025 | Activ.A.C. |
| Treace Medical Concepts, INC. | $29.52 | 2024-2025 | |
| Mimedx Group, INC. | $25.16 | 2025 | |
| Ossio INC | $20.48 | 2023 | |
| Urgo Medical North America, LLC | $16.37 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Merck Sharp & Dohme LLC | $15.86 | 2023 | Bridion |
| Kci USA, INC. | $12.02 | 2022 | |
| Stryker Corporation | $5.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.